Emergence of penicillin resistant pneumococci in Sri Lanka

N de Silva1, R Perera, L Mendis

  • 1Department of Microbiology, Faculty of Medicine, Colombo.

Insights

Penicillin-resistant pneumococci, identified in Sri Lankan children with meningitis, show varying resistance levels. Despite sensitivity to other antibiotics, one case demonstrated therapeutic failure with penicillin.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Penicillin-resistant (PR) pneumococci pose a growing global health threat.
  • Pneumococcal meningitis remains a significant cause of morbidity and mortality, particularly in children.
  • Emergence of antibiotic resistance necessitates continuous surveillance and characterization of resistant strains.

Purpose of the Study:

  • To report the isolation and characterization of penicillin-resistant pneumococcal strains from pediatric meningitis cases in Sri Lanka.
  • To determine the antimicrobial susceptibility profiles of these resistant strains.
  • To highlight the clinical implications of penicillin resistance in pneumococcal meningitis.

Main Methods:

  • Isolation of pneumococcal strains from cerebrospinal fluid (CSF) of two pediatric meningitis patients.
  • Detection of penicillin resistance using the oxacillin disc diffusion method (Stokes method).
  • Quantitative determination of penicillin susceptibility via agar dilution technique to establish Minimum Inhibitory Concentrations (MICs).
  • Testing sensitivity to a panel of other antibiotics including erythromycin, tetracycline, chloramphenicol, amoxycillin, cephalexin, and cefotaxime.

Main Results:

  • Two strains of penicillin-resistant (PR) pneumococci were identified.
  • MIC values of 2 µg/ml and 0.12 µg/ml indicated frank and intermediate penicillin resistance, respectively.
  • Both strains remained sensitive to erythromycin, tetracycline, chloramphenicol, amoxycillin, cephalexin, and cefotaxime.
  • Therapeutic failure was observed in the case with intermediate penicillin resistance despite penicillin treatment.

Conclusions:

  • Penicillin-resistant pneumococci have emerged in Sri Lanka, as evidenced by these pediatric meningitis cases.
  • The presence of both frank and intermediate resistance highlights the evolving challenge of pneumococcal infections.
  • Clinical vigilance is crucial, as therapeutic failure can occur even with intermediate resistance, underscoring the need for appropriate antibiotic selection.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...